Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

US Pharmaceuticals Ishares ETF (NY: IHE )

63.19 -0.13 (-0.21%)
Official Closing Price Updated: 8:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 236,663
Open 63.53
Bid (Size) 61.76 (24)
Ask (Size) 64.36 (23)
Prev. Close 63.32
Today's Range 63.12 - 63.74
52wk Range 63.12 - 208.68
Shares Outstanding 101,000
Dividend Yield 5.71%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher. 
Via Benzinga
A Look At Pharma ETFs After Q4 Earnings
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. 
Via Talk Markets
Topics ETFs

Performance

YTD
-66.35%
-66.35%
1 Month
-5.34%
-5.34%
3 Month
-66.59%
-66.59%
6 Month
-64.44%
-64.44%
1 Year
-64.94%
-64.94%

More News

Read More
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
Via Benzinga
Topics Bonds
Exposures Debt Markets
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
Via Talk Markets
Topics ETFs
Exposures COVID-19
3 Sector ETFs That Beat The Market Last Week
Via Talk Markets
Topics ETFs
US Pharmaceuticals: A Bifurcated Market
Via Talk Markets
5 Secret Santa ETFs That Might Surprise You This Christmas
Via Talk Markets
Topics ETFs
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
Via Benzinga
5 Sector ETFs That Outperformed in Turbulent August
Via Talk Markets
Topics ETFs
Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts
Via Talk Markets
Topics ETFs
Pharma ETFs in Focus Post Q2 Earnings
Via Talk Markets
Topics ETFs
3 Biotech Stocks to Sell in June Before They Crash and Burn
Via InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
Via Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
Via Talk Markets
4 Sector ETFs To Watch Ahead Of Mid-Election Results
Via Talk Markets
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority?
Via Benzinga
Pharma ETFs In Focus Post Q3 Earnings
Via Talk Markets
ETF Mid-Year Outlook & Investing Strategies
Via Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Via Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
Via Talk Markets
Exposures COVID-19
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Via Talk Markets
Exposures COVID-19 Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
Via Talk Markets
Exposures COVID-19
Tuesday Talk: Slip Sliding Sideways
Via Talk Markets
5 Sector ETFs That Survived Last Week's Turmoil
Via Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.